BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36522438)

  • 21. Molecular imaging of fibroblast activity in pressure overload heart failure using [
    Wang G; Yang Q; Wu S; Xu X; Li X; Liang S; Pan G; Zuo C; Zhao X; Cheng C; Liu S
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):465-474. PubMed ID: 36171409
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Gu Y; Han K; Zhang Z; Zhao Z; Yan C; Wang L; Fang W
    J Nucl Cardiol; 2023 Apr; 30(2):495-503. PubMed ID: 35322381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive visualization of liver fibrosis with [
    Song Y; Qin C; Chen Y; Ruan W; Gai Y; Song W; Gao Y; Hu W; Qiao P; Song X; Lv X; Zheng D; Chu H; Jiang D; Yang L; Lan X
    Eur J Nucl Med Mol Imaging; 2024 Jun; ():. PubMed ID: 38850311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [
    Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
    Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
    J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive Assessment of Renal Fibrosis of Chronic Kidney Disease in Rats by [
    Mao H; Chen L; Wu W; Zhang L; Li X; Chen Y; Huang Z; Ou S
    Mol Pharm; 2023 May; 20(5):2714-2725. PubMed ID: 37010328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome.
    Diekmann J; Koenig T; Thackeray JT; Derlin T; Czerner C; Neuser J; Ross TL; Schäfer A; Tillmanns J; Bauersachs J; Bengel FM
    J Nucl Med; 2022 Sep; 63(9):1415-1423. PubMed ID: 35210301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-Head Comparison of [
    Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
    Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension.
    Chen BX; Xing HQ; Gong JN; Guo XJ; Xi XY; Yang YH; Huo L; Yang MF
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1211-1222. PubMed ID: 34651221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application Value of 68 Ga-FAPI PET/CT in the Evaluation of Myelofibrotic Diseases.
    Liu Y; Li X; Jing L; Guo C; Wan Z; Zhang F; Wu P; Huang Z
    Clin Nucl Med; 2024 May; 49(5):404-408. PubMed ID: 38465921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
    Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
    J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [
    Chen R; Yang X; Yu X; Zhou X; Ng YL; Zhao H; Li L; Huang G; Zhou Y; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):929-936. PubMed ID: 36334106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-malignant findings of focal
    Zhang X; Song W; Qin C; Liu F; Lan X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2635-2641. PubMed ID: 33452634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.